Biofrontera- Warrants (27/10/2026) Operating Income

The latest operating income for BFRIW is $-6.6M as of June 2026. That compares with $-16M in the prior-year period — up 59.7% year over year. Investors often review this figure alongside Biofrontera- Warrants (27/10/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, BFRIW's operating income moved from $-16M to $-6.6M — a 59.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Biofrontera- Warrants (27/10/2026)'s operating scale or balance-sheet position.

A operating income figure of $-6.6M for BFRIW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BFRIW's operating income ($-6.6M), review year-over-year change from $-16M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Biofrontera- Warrants (27/10/2026)'s operating income against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.